NR1H4 and fatty liver disease: FXR expression in the gut was shown to mediate HFD-induced NAFLD, whereas liver-specific FXR activity protected against hepatic steatosis (Li et al., 2013; Jiang et al., 2015; Schmitt et al., 2015).